FindTrial
Sign In

Benefits of yoga in systemic sclerosis as compared to drugs alone : a pilot study

Benefit of yoga therapy in management of systemic sclerosis as compared to standard drug therapy alone :a pilot randomized control trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/01/022765
Enrollment
50
Registered
2020-01-14
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M349- Systemic sclerosis, unspecified

Interventions

Intervention1: 4 months yoga therapy to the study arm: Study arm will receive 4 months of yoga therapy in addition to the standard drug therapy. Patients will be instructed to do daily yoga at home fo

Sponsors

Department of Dermatology and Venereology
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients with systemic sclerosis who are greater than or equal to 18 years

Exclusion criteria

Exclusion criteria: 1. Patients unable to do the yoga intervention 2. Patients unable to follow up monthly

Design outcomes

Primary

MeasureTime frame
Improvement in quality of life of patients of systemic sclerosis after 4 months of yoga therapy assessed using SF-36Timepoint: 4 months—

Secondary

MeasureTime frame
Decrease in psychological impact of disease in patients of systemic sclerosis after 4 months of yoga therapy assessed using DASS-21Timepoint: 4 months;Improvement in pulmonary function of patients of systemic sclerosis after 4 months of yoga therapyTimepoint: 4 months;Improvement in skin changes in patients of systemic sclerosis after 4 months of yoga therapy assessed using mRSSTimepoint: 4 months—

Countries

India

Contacts

Public ContactDr Vaishnavi Verma

AIIMS New Delhi

neena_aiims@yahoo.co.in01126594985

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026